• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国成年人中一种新的非酒精性脂肪肝和肝纤维化指标之间的关联:2017 - 2018年美国国家健康与营养检查调查结果

Association between a new indicator with non-alcoholic fatty liver and liver fibrosis in US adults: findings from NHANES 2017-2018.

作者信息

Ji Mengyue, Li Maoxuan, Dong Na, Cao Jian, Du Xinru, Xu Ting, Shen Yingxiao, Luo Jiale, Ma Jialin, Li Yuan, Zhou Chunxiao

机构信息

Department of Gastroenterology, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, China.

The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, China.

出版信息

Transl Gastroenterol Hepatol. 2025 Jul 8;10:47. doi: 10.21037/tgh-24-151. eCollection 2025.

DOI:10.21037/tgh-24-151
PMID:40755739
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12314666/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) significantly threatens public health. Early diagnosis of NAFLD can prevent adverse outcomes, but the current diagnosis system is still imperfect. Serum markers and their combinations are valuable for detecting diseases, including NAFLD. The advanced lung cancer inflammatory index (ALI) is a comprehensive indicator that reflects the inflammation and nutritional status. Gamma-glutamyl transpeptidase (GGT) is an evaluation index for liver function. This study aims to construct a novel indicator based on ALI and GGT to evaluate NAFLD.

METHODS

A cross-sectional survey was conducted using data from the National Health and Nutrition Examination Survey (NHANES) 2017-2018. Binary logistic regression model and multivariate logistic regression model were utilized to examine the associations. Stratified and receiver operating characteristic (ROC) curve analyses were applied to confirm whether the dependent and independent variables had stable associations in the population.

RESULTS

This population-based study included 3,905 American adults. According to binary logistic regression analysis, an increase in ALI × GGT was significantly correlated with an increased risk of liver fibrosis, and multivariate logistic regression analysis confirmed that ALI × GGT was an independent risk factor for liver fibrosis. After grouping adjustment, we found that the diagnostic value of ALI × GGT was greater among participants under 50 years of age, women, those with diabetes mellitus or borderline diabetes, those without hypertension, and those without non-alcoholic fatty liver.

CONCLUSIONS

Our study revealed a new indicator, ALI × GGT, which could serve as a potential biomarker for early liver fibrosis in specific populations.

摘要

背景

非酒精性脂肪性肝病(NAFLD)严重威胁公众健康。NAFLD的早期诊断可预防不良后果,但目前的诊断系统仍不完善。血清标志物及其组合对疾病检测具有重要价值,包括NAFLD。晚期肺癌炎症指数(ALI)是反映炎症和营养状况的综合指标。γ-谷氨酰转肽酶(GGT)是肝功能的评估指标。本研究旨在构建基于ALI和GGT的新型指标以评估NAFLD。

方法

使用2017 - 2018年美国国家健康与营养检查调查(NHANES)的数据进行横断面调查。采用二元逻辑回归模型和多变量逻辑回归模型检验相关性。应用分层分析和受试者工作特征(ROC)曲线分析来确认在总体人群中因变量和自变量是否具有稳定的相关性。

结果

这项基于人群的研究纳入了3905名美国成年人。根据二元逻辑回归分析,ALI×GGT升高与肝纤维化风险增加显著相关,多变量逻辑回归分析证实ALI×GGT是肝纤维化的独立危险因素。分组调整后,我们发现ALI×GGT在50岁以下参与者、女性、患有糖尿病或边缘性糖尿病者、无高血压者以及无非酒精性脂肪肝者中诊断价值更大。

结论

我们的研究揭示了一个新指标ALI×GGT,它可作为特定人群早期肝纤维化的潜在生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf0/12314666/07599751c37b/tgh-10-24-151-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf0/12314666/646f2b4e9ada/tgh-10-24-151-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf0/12314666/e52121986a86/tgh-10-24-151-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf0/12314666/07599751c37b/tgh-10-24-151-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf0/12314666/646f2b4e9ada/tgh-10-24-151-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf0/12314666/e52121986a86/tgh-10-24-151-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/caf0/12314666/07599751c37b/tgh-10-24-151-f3.jpg

相似文献

1
Association between a new indicator with non-alcoholic fatty liver and liver fibrosis in US adults: findings from NHANES 2017-2018.美国成年人中一种新的非酒精性脂肪肝和肝纤维化指标之间的关联:2017 - 2018年美国国家健康与营养检查调查结果
Transl Gastroenterol Hepatol. 2025 Jul 8;10:47. doi: 10.21037/tgh-24-151. eCollection 2025.
2
Transient elastography for diagnosis of stages of hepatic fibrosis and cirrhosis in people with alcoholic liver disease.瞬时弹性成像技术用于诊断酒精性肝病患者的肝纤维化和肝硬化分期。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD010542. doi: 10.1002/14651858.CD010542.pub2.
3
The advanced lung cancer inflammation index has an L-shaped association with prognosis in American adults with metabolic dysfunction-associated fatty liver disease: a cohort study.晚期肺癌炎症指数与患有代谢功能障碍相关脂肪性肝病的美国成年人的预后呈L形关联:一项队列研究。
Front Nutr. 2025 Jul 7;12:1571511. doi: 10.3389/fnut.2025.1571511. eCollection 2025.
4
Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.用于非酒精性脂肪性肝病和非酒精性脂肪性肝炎的他汀类药物。
Cochrane Database Syst Rev. 2013 Dec 27;2013(12):CD008623. doi: 10.1002/14651858.CD008623.pub2.
5
Association of serum lactate dehydrogenase levels with non-alcoholic fatty liver disease and advanced hepatic fibrosis in the United States: a cross-sectional study using NHANES data from 2007 to 2018.美国血清乳酸脱氢酶水平与非酒精性脂肪性肝病及晚期肝纤维化的关联:一项利用2007年至2018年美国国家健康与营养检查调查(NHANES)数据的横断面研究
BMC Gastroenterol. 2025 Jul 1;25(1):467. doi: 10.1186/s12876-025-04057-w.
6
Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.非酒精性脂肪性肝病的营养补充:一项网状Meta分析。
Cochrane Database Syst Rev. 2021 Jul 19;7(7):CD013157. doi: 10.1002/14651858.CD013157.pub2.
7
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.非酒精性肝病患者小肠细菌过度生长的患病率:NAFLD、NASH、纤维化、肝硬化-系统评价、荟萃分析和荟萃回归。
Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261.
8
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
10
Vitamin E for people with non-alcoholic fatty liver disease.维生素 E 治疗非酒精性脂肪性肝病。
Cochrane Database Syst Rev. 2024 Oct 16;10(10):CD015033. doi: 10.1002/14651858.CD015033.pub2.

本文引用的文献

1
Comparative evaluation of APRI, FIB-4, HFS, and NFS: Scoring tools for liver fibrosis in a Mexican population with MASLD.APRI、FIB-4、HFS 和 NFS 的比较评估:MASLD 墨西哥人群中肝纤维化的评分工具。
Rev Gastroenterol Mex (Engl Ed). 2024 Oct-Dec;89(4):498-505. doi: 10.1016/j.rgmxen.2024.09.002. Epub 2024 Oct 2.
2
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).EASL-EASD-EASO 临床实践指南:代谢功能障碍相关脂肪性肝病(MASLD)的管理。
J Hepatol. 2024 Sep;81(3):492-542. doi: 10.1016/j.jhep.2024.04.031. Epub 2024 Jun 7.
3
Noninvasive diagnosis of significant liver inflammation in patients with chronic hepatitis B in the indeterminate phase.
慢性乙型肝炎不确定期患者显著肝脏炎症的非侵入性诊断。
Virulence. 2023 Dec;14(1):2268497. doi: 10.1080/21505594.2023.2268497. Epub 2023 Nov 8.
4
Blood Trihalomethane Concentrations and Osteoarthritis among U.S. Population Aged over 50 Years.50 岁以上美国人群血液三卤甲烷浓度与骨关节炎。
Environ Sci Technol. 2023 Oct 31;57(43):16166-16175. doi: 10.1021/acs.est.3c01495. Epub 2023 Oct 18.
5
Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver Disease.血清白蛋白水平与经活检证实的非酒精性脂肪性肝病患者长期预后的关系。
Nutrients. 2023 Apr 22;15(9):2014. doi: 10.3390/nu15092014.
6
Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017-2018.中性粒细胞与白蛋白比值(NPAR)对非酒精性脂肪性肝病和非糖尿病美国成年人中晚期肝纤维化的预测作用:来自 NHANES 2017-2018 的证据。
Nutrients. 2023 Apr 14;15(8):1892. doi: 10.3390/nu15081892.
7
Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease.应用 ELF 试验、FIB-4 和 NAFLD 纤维化评分对人群进行肝病筛查。
J Hepatol. 2023 Aug;79(2):277-286. doi: 10.1016/j.jhep.2023.04.002. Epub 2023 Apr 21.
8
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons.全球非酒精性脂肪性肝病发病率:63 项研究和 1,201,807 人的系统评价和荟萃分析。
J Hepatol. 2023 Aug;79(2):287-295. doi: 10.1016/j.jhep.2023.03.040. Epub 2023 Apr 9.
9
NAFLD, MAFLD and obesity: brothers in arms?非酒精性脂肪性肝病、代谢相关脂肪性肝病与肥胖:并肩作战的兄弟?
Nat Rev Gastroenterol Hepatol. 2023 Feb;20(2):67-68. doi: 10.1038/s41575-022-00717-4.
10
The advanced lung cancer inflammation index is the optimal inflammatory biomarker of overall survival in patients with lung cancer.晚期肺癌炎症指数是肺癌患者总生存期的最佳炎症生物标志物。
J Cachexia Sarcopenia Muscle. 2022 Oct;13(5):2504-2514. doi: 10.1002/jcsm.13032. Epub 2022 Jul 14.